THE CHANGING FACE OF CHOLESTEROL MANAGEMENT
The Healthcare Group at Frost & Sullivan is pleased to announce its Exclusive
Healthcare 2006 Quarterly Analyst Briefing Presentation on the U.S. Cholesterol
Drug market to be held on Thursday, February 16, 2006 at 2:00pm CST / 3:00pm
EST. Highlights of the briefing will include: market overview and forecast,
new treatment trends, selected recent important events as well as product highlights.
The statin class has now reached maturation, and pipeline development has moved
into other market areas. With four statin products facing their generic counterparts
in the next five years, it is up to new therapeutic trends and technology innovation
to generate the blockbuster products of the future.